SCHEMBL4602182

SCHEMBL4602182

NC(=O)CCc1ccc[nH]c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
MPO P05164 4/20 0.44
CAPN1 P07384 1/20 0.43
NAPRT Q6XQN6 1/20 0.43
DAO P14920 1/20 0.42
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
INCENP Q9NQS7 1/20 0.42
MTNR1A P48039 1/20 0.39
TYK2 P29597 1/20 0.38
SMYD3 Q9H7B4 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31013410 0.84 PARP1 (0.64) PARP1NAPRTDAOAURKAAURKB
SCHEMBL4590562 0.82 IAPP (0.50) PARP1NAPRTDAOAURKAAURKB
SCHEMBL4602730 0.81 NAPRT (0.46) PARP1NAPRTDAOAURKAAURKB
SCHEMBL5404670 0.77 AURKA (0.48) MPONAPRTDAOAURKAAURKB
SCHEMBL27088907 0.77 DAO (0.48) PARP1NAPRTDAOAURKAAURKB
SCHEMBL9321175 0.76 MTNR1A (0.47) MPOCAPN1MTNR1AKDM4EEGFR
SCHEMBL7130655 0.76 CAPN1 (0.47) MPOCAPN1NAPRTKDM4EEGFR
SCHEMBL9234355 0.75 DAO (0.45) PARP1NAPRTDAOAURKAAURKB
SCHEMBL6536604 0.74 DAO (0.45) PARP1NAPRTDAOAURKAAURKB
SCHEMBL4602524 0.74 CHEK1 (0.51) MPONAPRTDAOAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915363-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS AstraZeneca AB (SE) 2008-04-30 EP claimed
WO-2007018469-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-02-15 WO claimed
EP-1915363-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS AstraZeneca AB (SE) 2008-04-30 EP disclosed
WO-2007018469-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-02-15 WO disclosed